Status:
COMPLETED
Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care
Lead Sponsor:
University of Michigan
Conditions:
Venous Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The investigators aim to compare the complications between centrally and peripherally inserted central venous catheters in neurological intensive care unit patients. The study hypothesis is that perip...
Eligibility Criteria
Inclusion
- all patients age \> 18, admitted to the neurological ICU who are require a de novo central venous catheter as standard of care and in which a double lumen 5f PICC or CICVC (triple lumen, 7f) are acceptable for the indication.
- the patients must be expected to survive and need a central venous catheter for at least 7 days.
Exclusion
- prisoner
- age \< 18
- expected to die or have care withdrawn prior to ICU day 7
- requiring an emergent central venous catheter
- suspected bacteremia
- recent central venous catheter within the last 30 days
- patients who are not a candidate for bedside placement of either a CICVC or PICC line
- patients with renal insufficiency with creatinine level greater than 3.0 mg/dL (265.2 m mol/L) or who were undergoing hemodialysis
- patients requiring a central venous catheter for prolonged antibiotic therapy\\
- patient who the treating clinician feels clearly needs one particular type of catheter over the other
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01495429
Start Date
January 1 2012
End Date
July 1 2015
Last Update
August 4 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health System
Ann Arbor, Michigan, United States, 48103
2
Bronson Methodist Hospital
Kalamazoo, Michigan, United States, 49001